Canadian Consortium on Neurodegeneration in Aging

• MALDI-TOF imaging mass spectrometry demonstrates sex- and age-dependent spatial changes in brain energy metabolism in response to amyloid stress using a mouse model of Alzheimers Disease

  37794 (Phase I) and 163902 (Phase 2), 21 Sept 2026

Sources: api.crossref.org

• Integrating Novel Metabolomics Biomarkers with Multi‐modal Risk Factors in Predicting Mild Cognitive Impairment and Alzheimer's Disease

  AAIC 2025 abstract, 27 Dec 2025

• Can Thumbs UP: The Prevention arm of the Canadian Consortium on Neurodegeneration in Aging (CCNA)

  AAIC 2025 abstract, 25 Dec 2025

• Integrating polygenic risk scores, modifiable dementia risk factors, and sex as predictors of cohort membership in the Alzheimer’s and Lewy body disease spectra: A COMPASS‐ND Study

  AAIC 2025 abstract, 23 Dec 2025

• Efficacy of a cognitive and leisure‐based training program for older adults with a memory complaint: Results of the ENGAGE trial

  AAIC 2025 abstract, 23 Dec 2025

• The Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) Study neuropsychology battery of the Canadian Consortium on Neurodegeneration in Aging (CCNA): Design overview and initial validation

  1 Mar 2024